Lancet Report Calls for Holistic Care Model as HIV Population Ages Globally

By 2040, half of all people living with HIV worldwide will be over 50 years old. That demographic shift—from a disease once associated with early death to one increasingly managed across a lifetime—demands a fundamental rethinking of how health systems deliver care. A new report published this week in Lancet HIV makes the case that treating older adults with HIV requires far more than keeping their viral load suppressed. It requires rethinking medicine itself.

The commission, led by researchers at Johns Hopkins Bloomberg School of Public Health and Yale School of Medicine, drew on the expertise of 47 authors from around the world, including nine people living with HIV. Their central finding is stark: contemporary health systems are not built for what's coming. Nearly a third of the roughly 40 million people living with HIV globally were already over 50 in 2025. By 2040, that figure will reach half the population—some 20.2 million people. Many of them will have been managing HIV for decades, their bodies shaped by both the virus itself and the medications that have kept them alive.

The challenge is not simply medical complexity, though that is real. Older people with HIV tend to have what researchers call a physiologic age significantly higher than their actual years. The chronic infection itself accelerates aging. Add to that the cumulative effects of older antiretroviral drugs, the ongoing immune activation caused by HIV, and the standard array of age-related conditions—heart disease, diabetes, cognitive decline—and what emerges is a patient population that demands integration across specialties that rarely speak to one another. "It's not just about trying to control the HIV viral load," said Keri Althoff, one of the report's lead authors. "It's about how to keep the viral load suppressed while maintaining mental and physical health as a person's medical complexity increases with age."

The report's recommendations move beyond the standard antiretroviral therapy that has been the backbone of HIV care for decades. Yes, those drugs remain essential. But the authors call for systematic monitoring of functional decline, careful management of the multiple medications older adults typically take, active attention to mental health, and support for lifestyle changes that promote healthy aging. They also flag a problem often overlooked in clinical discussions: stigma and ageism compound the medical challenges. Older adults with HIV may avoid screening for new infections or seeking care for other conditions because of shame or fear of discrimination. Their changing circumstances—retirement, shifts in income, changes in sexual partnerships—create vulnerabilities that standard HIV prevention programs don't address.

Perhaps most damning is the report's assessment of how health systems are currently organized. Most operate as what researchers call "vertical services"—separate clinics with separate forms, separate schedules, separate billing. A patient might see an HIV specialist in one location, a cardiologist in another, a mental health provider in a third. Each operates independently. Each requires the patient to navigate bureaucracy and often pay out of pocket. This fragmentation works poorly for anyone managing multiple chronic conditions. For older adults with HIV, it can be catastrophic. "To provide appropriate care and support for healthy aging with HIV, we must change the care structure," Althoff said, "and link persons with HIV to community organizations and digital tools outside of the clinic walls."

The report, presented at the AIDS 2026 conference in Rio de Janeiro, does not offer a single blueprint. Instead, it calls for integration—better coordination between HIV programs and broader chronic disease management, innovations that embed geriatric expertise into HIV care, and crucially, partnerships with community organizations and digital platforms that extend care beyond the clinic. The vision is of care as a genuine partnership among patients, providers, and community, rather than a series of isolated encounters with specialists.

What makes this moment urgent is not just the numbers, though they are striking. It is that the window to prepare is closing. Health systems that continue to treat HIV as a discrete disease, managed in isolation from the rest of medicine, will find themselves overwhelmed within a decade. The people already living with HIV—who have survived against odds that seemed impossible thirty years ago—deserve better than a system that was never designed for them.